Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CASP2 | P42575 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1515376 | 0.86 | HPGD (0.43) | MEN1KMT2ANAAAHPGDCNR1 | |
| SCHEMBL23518488 | 0.86 | MEN1 (0.52) | TDP1MEN1KMT2ANAAAHPGD | |
| SCHEMBL4782817 | 0.84 | HPGD (0.47) | MEN1KMT2AHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL19827537 | 0.83 | PTGS1 (0.49) | PTGS1KCNH2TDP1MEN1KMT2A | |
| SCHEMBL4308618 | 0.83 | CASP2 (0.50) | MEN1KMT2ANAAAHPGDCNR1 | |
| SCHEMBL13374400 | 0.83 | MEN1 (0.43) | TDP1MEN1KMT2ANAAAHPGD | |
| SCHEMBL3067084 | 0.82 | DNM1 (0.54) | MEN1KMT2AHPGDALDH1A1KDM4E | |
| SCHEMBL20121987 | 0.81 | CASP2 (0.59) | MEN1KMT2ANAAAALDH1A1SMN1; SMN2 | |
| SCHEMBL20381018 | 0.81 | MEN1 (0.41) | MEN1KMT2ANAAAHPGDALDH1A1 | |
| SCHEMBL9035426 | 0.81 | MEN1 (0.41) | MEN1KMT2ANAAAHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4312968-A2 | COMPOSITION FOR TOPICAL APPLICATION TO A SUBJECT | G. Pohl-Boskamp GmbH & Co. KG (DE) | 2024-02-07 | — | — | EP | disclosed |
| EP-3131642-A1 | PATCH, SET OF PATCHES, METHOD AND USE FOR MEDICAL OR COSMETIC TREATMENT | Grasl, Jürgen (AT) | 2017-02-22 | — | — | EP | disclosed |
| WO-2015158841-A1 | PATCH, SET OF PATCHES, METHOD AND USE FOR MEDICAL OR COSMETIC TREATMENT | GRASL JÜRGEN (AT) | 2015-10-22 | — | — | WO | disclosed |
| US-8952031-B2 | Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2015-02-10 | — | — | US | disclosed |
| EP-2651514-A2 | ACTIVE INGREDIENT COMBINATION AND HAIR PREPARATIONS HAVING A REPAIR EFFECT | Henkel AG & Co. KGaA (DE) | 2013-10-23 | — | — | EP | disclosed |
| EP-2648691-A2 | ACTIVE INGREDIENT COMBINATION AND HAIR TREATMENT COMPOSITION | Henkel AG & Co. KGaA (DE) | 2013-10-16 | — | — | EP | disclosed |
| EP-2280933-B1 | 2 -AMINOTETRALIN DERIVATIVES AS MU OPIOID RECEPTOR ANTAGONISTS | THERAVANCE INC (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20120165360-A1 | AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | THERAVANCE, INC. (US) | 2012-06-28 | — | — | US | disclosed |
| WO-2012084336-A2 | HAIR TREATMENT PRODUCTS CONTAINING ONE OR MORE SURFACTANT(S) AND ONE OR MORE CATIONIC KERATIN HYDROLYSATE(S) | HENKEL AG & CO. KGAA (DE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012079873-A2 | ACTIVE INGREDIENT COMBINATION AND HAIR PREPARATIONS HAVING A REPAIR EFFECT | HENKEL AG & CO. KGAA (DE) | 2012-06-21 | — | — | WO | disclosed |
| WO-2011009763-A2 | COSMETIC CONTAINING PURINE AND/OR A PURINE DERIVATIVE AND SCLAREOL | HENKEL AG & CO. KGAA (DE) | 2011-01-27 | — | — | WO | disclosed |
| EP-2271309-A1 | SHAMPOO WITH FRUIT JUICE AND/OR VEGETABLE JUICE | Henkel AG & Co. KGaA (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2011000648-A2 | HAIR-PROTECTIVE COSMETIC I | HENKEL AG & CO. KGAA (DE) | 2011-01-06 | — | — | WO | disclosed |
| WO-2011000649-A2 | HAIR-PROTECTIVE COSMETIC II | HENKEL AG & CO. KGAA (DE) | 2011-01-06 | — | — | WO | disclosed |
| WO-2010086432-A2 | COLOR-PRESERVING HAIR TREATMENT AGENTS | HENKEL AG & CO. KGAA (DE) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010020516-A1 | NON-SULFATE MILD SURFACTANT SYSTEM FOR SKIN AND HAIR CLEANING | HENKEL AG & CO. KGAA (DE) | 2010-02-25 | — | — | WO | disclosed |
| WO-2009135699-A1 | SHAMPOO WITH FRUIT JUICE AND/OR VEGETABLE JUICE | HENKEL AG & CO. KGAA (DE) | 2009-11-12 | — | — | WO | disclosed |
| US-20090247627-A1 | AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-10-01 | — | — | US | disclosed |
| WO-2009083283-A1 | HAIR CLEANING PRODUCTS CONTAINING STRUCTURANTS | HENKEL AG & CO. KGAA (DE) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009083284-A1 | STABILIZATION OF HAIR CLEANING PRODUCTS | HENKEL AG & CO. KGAA (DE) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165360-A1 | AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | OPRL1, OPRM1, OPRD1 | PTGS1 443/4885KCNH2 1595/4885TDP1 4190/4885 |
| US-20090247627-A1 | AMINO- AND AMIDO-AMINOTETRALIN DERIVATIVES AND RELATED COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS | OPRL1, OPRM1, OPRD1 | PTGS1 443/4885KCNH2 1595/4885TDP1 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.